Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC25A48 antisense RNA 1 (SLC25A48-AS1), also known as LINC01959, is a long non-coding RNA gene located in the human genome and annotated as antisense to SLC25A48[2][5]. As a non-coding RNA, it is classified as a long intergenic non-protein coding RNA (lncRNA) and does not encode a protein product. Instead, like other lncRNAs, it may regulate gene expression at the transcriptional or post-transcriptional level, but currently, its function remains uncharacterized and there is no established role as a drug target, nor are there known interacting drugs or biomarker applications[5]. It is not considered a therapeutic target such as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLC25A48 antisense RNA 1 (SLC25A48-AS1).